These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 6768114)

  • 1. Endocrine and cytostatic treatment of experimental mammary cancer.
    Fiebig HH; Schmähl D
    Recent Results Cancer Res; 1980; 71():80-95. PubMed ID: 6768114
    [No Abstract]   [Full Text] [Related]  

  • 2. [Experimental toxicologic and therapeutic studies on the activity of the CMF(cyclophosphamide-methotrexate-5-fluorouracil) scheme versus the VMF(vincristine-methotrexate-5-fluorouracil) scheme].
    Berger MR; Habs M; Schmähl D
    Arch Geschwulstforsch; 1984; 54(4):263-78. PubMed ID: 6548622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Synergistic therapeutic effect of adriamycin with 5-fluor-uracil, with prednisolon and with cyclophosphamide on chemically induced mammary cancer of the rat (author's transl)].
    Fiebig HH; Schmähl D
    Klin Wochenschr; 1977 May; 55(9):445-50. PubMed ID: 406478
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of etoposide, carmustine, vincristine, 5-fluorouracil, or methotrexate on radiobiologically oxic and hypoxic cells in a C3H mouse mammary carcinoma in situ.
    Grau C; Overgaard J
    Cancer Chemother Pharmacol; 1992; 30(4):277-80. PubMed ID: 1643695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequential administration of two oncostatic drugs: study of modalities for pharmacodynamic potentiation.
    Pouillart R; Huong TH; Brugerie E; Lheritier J
    Biomedicine; 1974 Dec; 21(12):471-9. PubMed ID: 4462870
    [No Abstract]   [Full Text] [Related]  

  • 6. Recent progress in breast cancer management. Combined modality (adjuvant) therapy.
    Cowan K; Lippman M
    Arch Intern Med; 1981 Jul; 141(8):1055-9. PubMed ID: 7018440
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of ovariectomy, tamoxifen and the combination adriamycin and 5-FU on 7,12-dimethylbenz(a)anthracene induced mammary cancer of the rat.
    Fiebig HH; Schmähl D
    Oncology; 1977; 34(2):58-61. PubMed ID: 408773
    [No Abstract]   [Full Text] [Related]  

  • 8. Influence of five anti-cancer drugs on the induction and growth of experimental mammary cancers: comparison with ovariectomy.
    Rees ED; Ross A
    Cancer; 1968 Jun; 21(6):1029-41. PubMed ID: 4967489
    [No Abstract]   [Full Text] [Related]  

  • 9. Pathomorphological study of the cytotoxic effects of cyclic polychemotherapy on reproductive organs of female rats.
    Ageeva TA; Gvozdeva NV
    Bull Exp Biol Med; 2008 Dec; 146(6):791-3. PubMed ID: 19513385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [L 1210 leukemia, an experimental model for the potentiation of drugs used for acute leukemias].
    Pouillart P; Huong TH; Lhéritier J
    Bull Cancer; 1974; 61(4):509-26. PubMed ID: 4458834
    [No Abstract]   [Full Text] [Related]  

  • 11. [Adjuvant endocrine therapy and chemotherapy of breast cancer (author's transl)].
    Heuson JC; Paridaens R
    Rev Med Brux; 1982 Apr; 3(4):209-16. PubMed ID: 7046007
    [No Abstract]   [Full Text] [Related]  

  • 12. Noncarcinogenic chemotherapy with a combination of vincristine, methotrexate and 5-fluorouracil (VMF) in rats.
    Berger M; Habs M; Schmähl D
    Int J Cancer; 1983 Aug; 32(2):231-6. PubMed ID: 6874141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experiments on the influence of combined application of N-methylnitrosourea and 7,12-dimethylbenzanthracene in female Sprague-Dawley rats.
    Berger M; Künstler K
    Arch Geschwulstforsch; 1983; 53(5):423-7. PubMed ID: 6418112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of chemo-endocrine therapy on DMBA-induced rat mammary carcinoma].
    Yamamoto H; Morimoto T; Monden A
    Nihon Geka Gakkai Zasshi; 1989 Oct; 90(10):1786-92. PubMed ID: 2512479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemoendocrine therapy in advanced breast cancer.
    Kiang DT; Kennedy BJ
    Breast Cancer Res Treat; 1981; 1(2):105-9. PubMed ID: 6816316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disseminated breast carcinoma. Treatment with combination chemotherapy.
    Spigel SC; Coltman CA; Costanzi JJ
    Arch Intern Med; 1973 Oct; 132(4):575-7. PubMed ID: 4742410
    [No Abstract]   [Full Text] [Related]  

  • 17. [Cumulative effects of lentinan and endocrine therapy on the growth of DMBA-induced mammary tumor in rats].
    Kosaka A; Imaizumi A; Hatori Y; Mori F; Wani T; Yamashita A
    Gan To Kagaku Ryoho; 1984 Jul; 11(7):1399-407. PubMed ID: 6430243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor activity of menogaril alone, and in combination against human mammary cancer models in mice and rats.
    Yoshida M; Fujioka A; Nakano K; Kobunai T; Saito H; Toko T; Takeda S; Unemi N
    Anticancer Res; 1996; 16(3A):1155-9. PubMed ID: 8702227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination chemotherapy in advanced breast cancer. A report of the Working Party of the Multicentre Cancer Chemotherapy Group.
    Spittle MF; Bates TD; Kitchen G; Nicol NT; Wheeler T; Edelstyn G; MacRae KD; Ostrowski MJ
    Clin Oncol; 1980 Jun; 6(2):153-7. PubMed ID: 7408282
    [No Abstract]   [Full Text] [Related]  

  • 20. Influence of dosage schedule on the biological characteristics of N-nitrosomethylurea-induced rat mammary tumors.
    Rose DP; Pruitt B; Stauber P; Ertürk E; Bryan GT
    Cancer Res; 1980 Feb; 40(2):235-9. PubMed ID: 7356506
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.